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Lumenal delivery of adenovirus vectors (AdV) results in inefficient gene transfer to human airway epithe-
lium. The human coxsackievirus and adenovirus receptor (hCAR) was detected by immunofluorescence selec-
tively at the basolateral surfaces of freshly excised human airway epithelial cells, suggesting that the absence
of apical hCAR constitutes a barrier to adenovirus-mediated gene delivery in vivo. In transfected polarized
Madin-Darby canine kidney cells, wild-type hCAR was expressed selectively at the basolateral membrane,
whereas hCAR lacking the transmembrane and/or cytoplasmic domains was expressed on both the basolateral
and apical membranes. Cells expressing apical hCAR still were not efficiently transduced by AdV applied to the
apical surface. However, after the cells were treated with agents that remove components of the apical surface
glycocalyx, AdV transduction occurred. These results indicate that adenovirus can infect via receptors located
at the apical cell membrane but that the glycocalyx impedes interaction of AdV with apical receptors.
Cystic fibrosis (CF) is a progressive multisystem disease that
results from a defect in the CF transmembrane conductance
regulator (CFTR). Gene therapy strategies for CF lung disease
have focused on delivery of the CFTR gene to airway epithelial
cells by way of the airway lumen. Despite encouraging initial
results, clinical trials using viral and nonviral vectors to deliver
CFTR to the airway epithelium have not achieved significant
functional correction of the primary CF defect (for a review,
see reference 10). The failure of CF gene therapy thus far may
be due to both inefficient gene transfer to the airway epithe-
lium and host immune responses that severely limit the extent
and duration of transgene expression.
Expression of the coxsackievirus and adenovirus receptor
(CAR) is a major determinant of the susceptibility of a cell to
adenovirus vector (AdV)-mediated gene transfer (3, 19). The
low efficiency of AdV-mediated gene transfer to well-differen-
tiated polarized airway epithelial cells has been related to the
absence of virus receptors from the apical (or lumenal) surface
of the epithelium. In cell culture models of human well-differ-
entiated airway epithelial cells, both functional and immuno-
fluorescence methods have detected the expression of human
CAR (hCAR) at the basolateral surfaces but not at the lume-
nal surfaces of these cells (17, 22, 30). These observations may
explain, at least in part, the difficulties encountered in attempt-
ing successful lumenal gene delivery to the intact epithelium.
One way to achieve efficient gene delivery, despite the ab-
sence of hCAR from the apical surface of the airway epithe-
lium, is to reengineer AdV to target receptors that are present
at the apical surface (5, 12a). Targeting of AdV to alternate
receptors has been achieved by several strategies, with im-
provements in gene transfer efficiency reported in a variety of
cell types (8, 9, 24–27). At present, however, there is still a
paucity of identified molecules on the apical surface of the
airway epithelium that could act as surrogate receptors for
AdV attachment and entry. To test the hypothesis that gene
transfer efficiency can be enhanced by targeting AdV to spe-
cific apical receptors, we have reengineered hCAR to direct its
expression to the apical membrane in a model of polarized
epithelium. Having achieved apical expression of the “natural”
AdV attachment receptor, we then determined whether effi-
cient gene transfer with lumenal delivery of AdV could be
achieved.
MATERIALS AND METHODS
hCAR localization in human airway epithelial cells and hCAR-transfected
MDCK cells. Frozen sections of human CF- and non-CF-derived cultured tra-
cheobronchial airway cells and of CF and non-CF tissues obtained at the time of
lung transplantation were briefly fixed in ice-cold methanol. The sections were
incubated with the anti-hCAR monoclonal antibody RmcB (ascites fluid; 1/500
dilution in phosphate-buffered saline [PBS] containing 10% normal goat serum
[NGS]), followed by goat anti-mouse immunoglobulin G (IgG)-Texas red (Jack-
son Immunoresearch Laboratories, Inc., West Grove, Pa.) (1/400 dilution in
PBS–10% NGS). Control sections were treated as described above except that
RmcB was either omitted from the protocol or replaced with nonimmune ascites
fluid (Jackson Immunoresearch Laboratories, Inc.). The tissues were mounted
with VectorShield containing 49,6-diamidino-2-phenylindole (DAPI) (Vector
Laboratories, Burlingame, Calif.). Representative images were taken with a
Leica TCS/4D confocal microscope. All tissues were obtained under institutional
review board-approved protocols.
Wild-type, tailless (hCARtls), and glycosylphosphatidylinositol (GPI)-linked
(hCARgpi) hCAR cDNA constructs in the pcDNA 3.1 expression vector have
been previously described (23). Madin-Darby canine kidney type 2 (MDCK) cells
were transfected by electroporation, and the transfected cells were selected in
medium containing 500 mg of Geneticin (Gibco-BRL Life Technologies, Gaith-
ersburg, Md.). A control cell line (MDCK-Neo) was transfected with the vector
alone. Cell populations with surface hCAR expression were isolated by fluores-
cence-activated cell sorting with RmcB, using fluorescein isothiocyanate-conju-
gated goat antibody to murine immunoglobulin (Sigma-Aldrich, Saint Louis,
Mo.) for detection and the murine myeloma protein MOPC 195 (Sigma-Aldrich)
as a negative control. MDCK cells expressing the constructs were grown on
permeable supports (Transwell-Clears; diameter, 12 mm; Corning-Costar Corp.,
Cambridge, Mass.) until polarization of the cultures and the development of
“tight” transepithelial resistances (TER, .700 V cm22) as measured with an
epithelial voltohmmeter (World Precision Instruments, Inc., Sarasota, Fla.).
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To test for RmcB immunoreactivity in polarized MDCK cultures, the cells
were fixed in paraformaldehyde (2% in PBS), washed, permeabilized with Triton
X-100 (0.2%), and blocked with 10% NGS before incubation with RmcB (1:1
dilution of hybridoma tissue culture supernatant in 10% NGS) and then with
goat anti-mouse IgG-Texas red. The cells were examined by confocal microscopy
in both XY and XZ planes. The cells incubated with control culture supernatants
or regular medium, rather than with RmcB, showed no fluorescent staining.
Adenovirus-mediated gene transfer. The apical surfaces of polarized MDCK
cell monolayers expressing hCAR, hCARtls, hCARgpi, or Neo were washed
extensively in PBS before exposure to AdV type 5 encoding green fluorescent
protein (GFP) (Quantum Biotechnologies, Montreal, Ontario, Canada) (cyto-
megalovirus promoter) or b-galactosidase (cytomegalovirus promoter [17]) at
1010 particles per well for 2 h at room temperature. The adenovirus particle/
infectious unit ratio was routinely 100:1 and was determined exactly as described
previously (17). Therefore, 1010 particles approximated 108 infectious units/well,
corresponding to a multiplicity of infection of ;100 given 106 cells/well. To test
the specificity of the AdV-CAR interaction, parallel cultures were incubated with
excess fiber knob protein (25 mg/ml [17]) in the presence of AdV. Transgene
expression was assessed 48 h later by epifluorescence microscopy (for GFP) or
luminescent enzymatic assay (Galactolight Plus; Tropix, Bedford, Mass.) for
b-galactosidase using the manufacturer’s recommended protocols. For radiola-
beled virus binding studies, 1010 particles of [35S]methionine-labeled AdV LacZ
were exposed to the apical surfaces of MDCK cell lines in either the absence or
presence of purified fiber knob protein (25 mg/ml) for 2 h at 4°C after exposure
FIG. 1. Immunolocalization of hCAR expression in human airway epithelial cells. Frozen sections of human non-CF tracheobronchial airway epithelial cells
cultured on permeable supports (A and E) (17) or of human non-CF airway tissue derived from the tracheobronchial (B and F), submucosal glandular (C and G), or
bronchiolar (D and H) regions were fixed and incubated with either control IgG or the anti-CAR monoclonal IgG antibody RmcB and examined by confocal microscopy
as described in Materials and Methods. Specific staining was observed only in those tissues exposed to anti-CAR and was localized to the lateral aspects of all the surface
epithelial cells (arrowheads). Magnification, 340.
VOL. 74, 2000 CAR EXPRESSED ON APICAL SURFACES OF POLARIZED CELLS 6051
to serum-free medium alone or neuraminidase (NA) as described below. After
being extensively washed, the cell-associated radioactive counts per minute were
assessed by liquid scintillation counting. The production of 35S-labeled AdV was
as previously described (17). Transmission electron microscopy was performed
on MDCK cell lines after the cultures had been exposed to 1010 particles of AdV
LacZ for 2 h at room temperature. Fixation and processing of the tissues was
performed exactly as previously described (17).
Enzymatic treatments and lectin binding of MDCK cells. Monolayers were
incubated with NA (NA III; Sigma-Aldrich) (80 mU/well; 160 mU/ml) diluted in
serum-free culture medium for 2 h at 37°C and washed with PBS before exposure
to virus. Control monolayers were incubated with serum-free medium alone. In
other experiments, monolayers were incubated with trypsin (300 U/ml; Sigma),
human leukocyte elastase (0.2 U/ml; Sigma), endoglycosidase H (0.2 U/ml;
Sigma), heparinase (0.025 U/ml; Sigma), heparitinase (0.01 U/ml; Sigma), chon-
dro-4-sulfatase (1 U/ml; Seikagaku Corp., Tokyo, Japan), chondroitinase-ABC
(0.4 U/ml; Seikagaku), or keratanase (1 U/ml; Seikagaku).
To detect the enzymatic effect of NA on cell surface carbohydrates, cell
monolayers were incubated with both fluorescein-conjugated Sambucus nigra
lectin (SNA; 20 mg/ml) and rhodamine-conjugated peanut agglutinin lectin
(PNA; 20 mg/ml) (Vector Laboratories) for 1 h at room temperature and then
examined by fluorescence microscopy.
RESULTS
CAR is restricted to the basolateral surface of well-differ-
entiated human airway epithelium. In cell-culture models of
human well-differentiated mucociliary polarized airway epithe-
FIG. 2. CAR expression on transfected MDCK cells. Cells transfected with wild-type hCAR, hCARtls, or hCARgpi or with expression vector alone (Neo) were
incubated with RmcB (solid line) or with a control IgG (dotted line), followed by fluorescein isothiocyanate-conjugated secondary antibody, and then analyzed for CAR
expression by flow cytometry. The mean cell fluorescence (MCF) for each cell line was corrected by subtracting the mean fluorescence of cells stained with control
antibody.
FIG. 3. Immunolocalization of mutant hCAR constructs in polarized MDCK epithelial cells. Polarized MDCK cells transfected with wild-type hCAR, hCARtls, or
hCARgpi or with expression vector alone (Neo) were cultured on permeable supports and then fixed, permeabilized, stained with anti-CAR, and examined by confocal
microscopy as described in Materials and Methods. No fluorescent staining was seen in controls with nonimmune IgG. Magnification, 317.6 (XY) and 335.2 (XZ)
(original magnification, 320 [XY] and 340 [XZ]).
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lium, hCAR expression is restricted to the basolateral mem-
brane and absent from the apical surface (17, 22). To deter-
mine whether the distribution of hCAR is similar in freshly
excised human airway epithelium, we probed human non-CF
and CF airway tissue sections with the anti-hCAR monoclonal
antibody RmcB and detected RmcB binding by antibody-
linked immunofluorescence (Fig. 1).
For both the cultured cells and the surface epithelium of the
tracheobronchial and bronchiolar regions, hCAR expression
was most evident in the lateral aspects of the cells and pro-
nounced at regions that appeared to correspond to tight junc-
tional complexes (Fig. 1). hCAR expression in submucosal
glands showed a more widespread expression pattern, outlin-
ing the entire basolateral membrane. These results show that
in freshly excised tissue, hCAR expression is restricted to the
lateral and basolateral regions of airway epithelial cells. This
suggests that in vivo, as previously demonstrated in well-dif-
ferentiated cultured cells, hCAR is not expressed at the apical
surface and thus is unavailable for an interaction with AdV
delivered to the airway lumen. Similar results were obtained
for both CF and non-CF tissue (results not shown).
Retargeting hCAR expression to the apical surfaces of po-
larized epithelial cells. hCAR is a membrane-spanning protein
consisting of an N-terminal extracellular domain containing
the AdV binding site, a transmembrane domain, and a C-
terminal cytoplasmic domain. CAR variants lacking the cyto-
plasmic domain (hCARtls), or attached to the cell surface by a
GPI-linked anchor and lacking both transmembrane and cyto-
plasmic domains (hCARgpi), both function in adenovirus-me-
diated gene delivery to nonpolarized cells (23). Since GPI-
anchored proteins are reported to be expressed preferentially
on the apical surfaces of polarized cells (7, 13), and some
protein cytoplasmic domains contain signals that result in ex-
pression targeted to the basolateral membrane (20), we tested
whether hCARtls and hCARgpi were expressed on the apical
membranes of polarized cells.
Wild-type hCAR, hCARtls, and hCARgpi were expressed in
MDCK cells, which are also resistant to AdV-mediated gene
transfer via the apical membrane and are a well-characterized
model for studies of epithelial cell polarization (1, 29). The
surface expression levels of hCAR were similar in all three cell
lines, as determined by flow cytometry (Fig. 2). Transfected
cells were grown to confluence as polarized cultures, and ex-
pression of the hCAR variants was examined by confocal mi-
croscopy (Fig. 3). Expression of full-length hCAR was re-
stricted to the basolateral membranes of the polarized MDCK
cells, as was evident both by the characteristic cobblestone
pattern (XY plane) and the basolateral location (XZ plane) of
RmcB immunoreactivity. The expression of hCAR in trans-
fected MDCK cells thus recapitulates the expression pattern
for hCAR in polarized human airway epithelium. In contrast,
hCARtls and hCARgpi expression occurred at both the apical
and basolateral surfaces of the polarized cells. Interestingly,
FIG. 4. AdV-mediated gene transfer to MDCK cells before and after NA
treatment. The apical surfaces of transfected MDCK cells were treated with NA
(1NA) or left untreated (2NA) before exposure to AdV. (A) Monolayers
exposed to AdV encoding GFP, with transgene expression detected by fluores-
cent microscopy at 48 h. Magnification, 3 4.2 (original magnification, 35). (B)
Monolayers exposed to AdV encoding b-galactosidase, with detection by chemi-
luminescence assay. Parallel cultures were incubated with excess fiber knob
protein (Fk; 25 mg/ml) in addition to AdV. The error bars represent the standard
errors of the mean for at least four samples.
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hCARtls expression appeared to be distributed equally be-
tween apical and basolateral surfaces, while hCARgpi expres-
sion was expressed preferentially at the apical surfaces of the
cells. These results indicate that in a model of polarized epi-
thelial cells, hCAR can be expressed at the apical surface,
where it may be available for interaction with lumenally ap-
plied AdV.
Inefficient gene delivery mediated by apical CAR. To deter-
mine whether expression of a specific AdV attachment site at
the apical surfaces of polarized epithelial cells is sufficient to
allow for AdV transduction, AdV encoding GFP was applied
to the apical surfaces of polarized MDCK cells expressing
hCARtls and hCARgpi, using both hCAR- and Neo-expressing
MDCK cells as controls. Under incubation conditions that
were previously determined to be optimal for AdV transduc-
tion of nonpolarized MDCK-hCAR cells (results not shown),
apical exposure to AdV resulted in little or no GFP expression
in hCAR- and Neo-expressing MDCK cells, with only slightly
more expression in hCARtls and hCARgpi cells (Fig. 4A). The
low gene transfer efficiency, even in cells expressing an apical
AdV attachment receptor, suggested that additional barriers to
AdV gene transfer existed at the apical surfaces of polarized
epithelial cells.
Removal of glycocalyx components permits efficient gene
delivery mediated by apical CAR. The access of AdV to the
attachment site may be restricted by additional extracellular
barriers expressed at the apical surface. Alternatively, hCARtls
and hCARgpi complexed with AdV may not internalize across
the apical membrane, or if internalized may not enter an in-
tracellular compartment appropriate for subsequent events in
gene delivery. Recent reports indicate that polarized epithelial
cells are more sensitive to virus-mediated gene transfer after
exposure to agents that affect the cell surface glycocalyx (1, 2).
We therefore tested whether removal of the sialic acid com-
ponent of the glycocalyx enhanced the susceptibility of polar-
ized cells expressing apical CAR by incubating the apical sur-
faces of these cells with NA before exposing them to AdV-
GFP. High levels of GFP expression were observed in NA-
treated MDCK cells expressing hCARtls and hCARgpi but not
in NA-treated cells expressing wild-type hCAR or Neo alone
(Fig. 4A).
These results were confirmed using an AdV encoding b-ga-
lactosidase (AdV–b-Gal) that permitted enzymatic quantita-
tion of gene expression (Fig. 4B). As was seen with GFP, little
gene transfer to MDCK-Neo or MDCK-hCAR was observed
either with or without NA treatment. In contrast, in NA-
treated cells expressing apical hCARtls and hCARgpi, b-galac-
tosidase levels were markedly enhanced (30- to 40-fold) com-
pared to levels in cells not treated with NA. In cells treated
with NA, gene expression was reduced in cells exposed to
excess purified AdV fiber protein before incubation with AdV–
b-Gal, indicating that, as expected, apical gene delivery re-
FIG. 5. Effects of NA treatment on MDCK cell lines. (A) Removal of ter-
minal sialic acid residues. The apical surfaces of MDCK-hCARgpi cells were
probed with fluorescein-conjugated SNA lectin (green fluorescence) and rho-
damine-conjugated PNA lectin (red fluorescence) in cultures without (2NA)
and with (1NA) prior exposure to NA. Similar distribution patterns for SNA and
PNA before and after NA treatment were observed for all four transfected
MDCK cell lines. Magnification, 35. (B) Transepithelial resistance measure-
ment before and after NA treatment of the apical surfaces of the respective cell
lines. The open bars represent the resistances of the respective cultures before
exposure to serum-free medium alone or NA (n 5 36); the hatched bars repre-
sent the resistances of the respective cultures after exposure to serum-free
medium alone (n 5 18); and the solid bars represent the resistances of respective
cultures after exposure to NA (n 5 18).
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quired interaction of the AdV fiber protein with its primary
receptor, hCAR.
The gene transfer enhancement observed with NA treat-
ment was reversible: cultures expressing CARgpi treated with
NA regained resistance to AdV transduction after approxi-
mately 12 h (results not shown), suggesting a regeneration of
sialic acid-containing components of the glycocalyx.
The enzymatic action of NA on glycocalyx structures is to
specifically remove terminal sialic acid residues. The reduction
of the negative charge of the glycocalyx by removal of sialic
acid may permit AdV to reach the apically expressed receptors.
However, increased AdV-mediated gene transfer to polarized
epithelial cells has also been observed when cells are treated
with reagents that disrupt epithelial tight junctions, allowing
lumenally applied AdV to gain access to CAR expressed at
the basolateral surface (22; C. B. Coyne, M. M. Kelly, R. C.
Boucher, and L. J. Johnson, submitted for publication). To test
whether NA was removing terminal sialic acid residues of the
MDCK glycocalyx, the apical surfaces of NA-treated or un-
treated polarized MDCK cells were probed with the specific
lectins SNA and PNA. SNA binds to terminal sialic acid resi-
dues, whereas PNA recognizes specific galactosyl residues nor-
mally “hidden” by terminal sialylation (1). Untreated MDCK
cells reacted primarily with SNA but not PNA, whereas after
NA treatment, PNA staining but not SNA staining was ob-
served (Fig. 5A). This finding confirmed that NA removed
terminal sialic acid from apically located structures, i.e., the
glycocalyx, on MDCK cells as has been previously reported (1).
To determine whether NA treatment had an effect on tight
junctional permeability, we measured TER across the polar-
ized MDCK cells. High electrical resistance, indicative of tight
epithelial junctions, was observed in all the cultures both be-
fore and after NA treatment (Fig. 5B). In other experiments
with MDCK cells, in which cation chelation was used to open
tight junctions and permit AdV access to basolateral CAR,
enhanced gene transfer was accomplished only after a reduc-
tion of TER to values below 150 V cm22 (Coyne et al., sub-
mitted). Clearly, NA treatment did not affect TER to this
extent. The observation that NA treatment did not result in a
significant increase in the transduction of cells expressing wild-
type hCAR on the basolateral surface also indicated that virus
did not leak from the apical to the basolateral compartment
and provides further evidence that NA treatment did not result
in significant disruption of the tight junctional boundary. These
results indicated that NA enhanced gene transfer not by dis-
rupting tight junctions but instead by an effect on sialylated
structures that interfered with virus access to receptors on the
apical surface.
Some heavily glycosylated cell surface proteins, such as the
mucin MUC-1, project far above the cell membrane (6) and
might effectively shield receptor sites on the cell surface from
interacting with AdV. The negative charge provided by heavily
sialylated and sulfated glycoproteins may also hinder virus
access. Alternatively, virus may adsorb nonspecifically to the
glycocalyx and fail to reach receptor sites that permit internal-
ization. To begin to examine these possibilities, which are not
mutually exclusive, we exposed the apical cell surfaces of
hCAR cells and hCARgpi cells to radiolabeled AdV, both with
and without NA treatment (Fig. 6A). Significantly less virus
bound to NA-treated hCAR cells than to untreated cells, sug-
gesting that virus bound to the glycocalyx itself; in contrast, NA
treatment increased the capacity of hCARgpi cells to bind virus.
Virus binding to NA-treated hCARgpi, but not to hCAR cells,
was inhibited by pretreatment with excess fiber knob. These
results suggest that nonspecific attachment of virus to the gly-
cocalyx may impede specific interaction with CAR. Electron
microscopic examination of polarized epithelial cells (Fig. 6B)
also suggests that virus may become enmeshed within the gly-
cocalyx, which likely serves both as a physical barrier and as a
nonspecific trap preventing virus attachment to the cell sur-
face.
The cellular glycocalyx is composed of many carbohydrate-
bearing structures, including glycoproteins, glycolipids, and
proteoglycans, whose glycosaminoglycans may contain keratan
sulfate (21), chondroitin sulfate (4), and heparan sulfate (28).
We examined enzymes that may act on these structures to
determine whether agents in addition to NA could also facil-
itate AdV interaction with apically expressed receptors. Tryp-
sin, keratanase, and human leukocyte elastase enhanced gene
transfer with AdV to hCARgpi cells without significantly alter-
ing gene transfer to hCAR cells (Fig. 7). None of these re-
agents affected the levels of hCAR or hCARgpi expression as
measured by RmcB immunofluorescence (not shown). Treat-
ment with endoglycosidase H, heparinase, heparitinase, chon-
dro-4-sulfatase, and chondroitinase-ABC did not enhance
gene transfer to cells expressing apical hCAR (not shown).
FIG. 6. Nonspecific attachment to and receptor shielding properties of gly-
cocalyx. (A) Radiolabeled AdV attachment to the apical surfaces of MDCK-
hCAR and MDCK-hCARgpi cells either without (2NA) or with (1NA) prior
treatment with NA. The specificity of the AdV-receptor interaction was deter-
mined by coincubation of purified fiber knob protein (Fk; 25 mg/ml) with AdV.
Note that virus attachment to CAR cells is reduced after NA pretreatment
whereas attachment to hCARgpi is enhanced only after NA pretreatment. (B)
Transmission electron micrograph of the surfaces of polarized epithelial cells
after exposure to AdV for 2 h at room temperature. The arrows show AdV
entangled in the cellular glycocalyx. Note the projection of the glycocalyx from
the microvilli extending 0.5 to 1 mm from the cell surface.
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DISCUSSION
The resistance of the lumenal surfaces of polarized epithelial
cells to AdV-mediated gene transfer has been reported to be
due to the absence of specific high-affinity attachment sites on
this membrane (17, 22). We found, in freshly excised airway
specimens that reflect the status of the tissue in vivo, that
hCAR is absent from the lumenal surface, as it is in cultured
airway epithelium (Fig. 1). It is therefore likely that, in vivo as
well as in vitro, the absence of specific AdV receptors is the
primary obstacle to efficient AdV-mediated gene delivery.
To determine whether the absence of apical AdV attach-
ment sites is the sole reason for the low transduction efficiency
with lumenal administration of AdV, we retargeted hCAR to
the apical surfaces of polarized epithelial cells (Fig. 3). We
found that virus interaction with apical hCAR permitted effi-
cient gene transfer across the apical membrane. However,
these studies revealed an additional major barrier to lumenally
delivered gene transfer vectors: significant gene transfer oc-
curred only when cells were pretreated with specific enzymes,
such as NA, that disrupt components of the cell coat, or gly-
cocalyx (Fig. 4 and 6). Thus, the cellular glycocalyx served as a
physical barrier preventing virus access to recombinant hCAR
expressed at the apical cell surface.
Other investigators have noted that disruption of the glyco-
calyx enhances the susceptibility of polarized cells to transduc-
tion by AdV (1) and adeno-associated virus vectors (2). How-
ever, in these previous studies, the improvements in gene
transfer efficiency were modest, most likely due to the absence
of specific high-affinity receptors for the respective vectors on
the cell surface. We have demonstrated that even in the pres-
ence of high-affinity receptors at the apical membrane, the
glycocalyx interfered with virus-mediated gene delivery.
The glycocalyx may function as an innate defense against
viral and nonviral pathogens, but the mechanism of its protec-
tive effects is uncertain. The glycocalyx is composed of many
carbohydrate-bearing structures, including glycoproteins, gly-
colipids, and proteoglycans. We have not attempted to identify
the specific components within the glycocalyx that are respon-
FIG. 7. Specific enzymatic reagents other than NA enhance AdV-mediated gene transfer specifically to MDCK-CARgpi cells. The apical surfaces of the transfected
MDCK cells were exposed to serum-free medium alone (control), trypsin, keratanase, or human leukocyte elastase as described in Materials and Methods. After the
cells were washed, AdV-GFP was exposed to the apical surfaces. Transgene expression was observed 48 h later by epifluorescence microscopy. The results with
MDCK-Neo resembled those with MDCK-hCAR, and MDCK-CARtls showed results similar to those obtained with MDCK-CARgpi (not shown). Magnification, 35.
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sible for the barrier function in MDCK cells. Preliminary data
suggest that the glycocalyx present on the apical surface of
human airway epithelial cells is more abundant than and dif-
ferent in composition from the glycocalyx of MDCK cells: for
example, human airway epithelial cells express MUC-1
whereas MDCK cells do not (1). These findings suggest that
the glycocalyx on human airway epithelium may pose a greater
obstacle to gene transfer than the one we observed with
MDCK cells.
Both tailless and GPI-anchored hCARs appear on the apical
surfaces of polarized cells, consistent with the general obser-
vation that protein sorting to the basolateral membrane is
determined by signals within the cytoplasmic domain (14).
Many of these signals resemble tyrosine- or leucine-containing
sequence motifs responsible for protein localization and endo-
cytosis in clathrin-coated pits (15). Protein targeting in polar-
ized epithelial cells may also involve interactions with scaffold-
ing proteins containing PDZ domains (11, 12, 16), which are
known to recognize hydrophobic C-terminal peptides within
their partners (18). It remains to be determined whether the
hydrophobic CAR C terminus, tyrosine-containing motifs, or
other signals are responsible for basolateral targeting. Identi-
fication of such signals may lead to strategies that will permit
apical relocalization of CAR, although the feasibility of this
type of experimental manipulation in vivo is undetermined.
Multiple approaches have been proposed to improve the
efficiency of gene transfer to the human airway epithelium (5).
Divalent cation chelation has been shown to disrupt tight junc-
tions, permitting virus access to basolateral CAR (22; Coyne et
al., submitted). Alternatively, several approaches to redirecting
vectors to nonvirus receptors on the apical membrane have
been proposed (5, 12a). However, it is not clear that all sur-
rogate receptors present at the apical membrane will be suffi-
cient to accommodate virus penetration and delivery of the
transgene to the nucleus.
All gene transfer vectors delivered to the surface of the
airway epithelium will likely face the obstacle posed by the
glycocalyx. Further investigation of the composition and struc-
ture of the cellular glycocalyx on the apical surfaces of epithe-
lial cells will be required to identify the specific moieties that
hinder the interaction of vectors with receptors located at the
apical surface and to safely circumvent these barriers to
achieve efficient gene transfer.
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